WUXI VACCINES Trademark

Trademark Overview


On Tuesday, July 20, 2021, a trademark application was filed for WUXI VACCINES with the United States Patent and Trademark Office. The USPTO has given the WUXI VACCINES trademark a serial number of 79331562. The federal status of this trademark filing is REGISTERED as of Tuesday, February 28, 2023. This trademark is owned by Shanghai Vaccines Co., Ltd.. The WUXI VACCINES trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom assembling of materials for others being custom manufacture of pharmaceuticals, chemotherapy drugs, antibiotic medicines, and vaccines by pharmaceutical compounders; custom manufacture of pharmaceuticals medical preparation; customized production service being custom manufacturing of pharmaceuticals; customized production service being custom manufacturing of vaccines; medicinal materials processing being custom manufacture of pharmaceuticals; processing and treatment of chemical reagents, namely, custom production of reagents for scientific or medical research use; processing of pharmaceutical materials for others being processing of medicinal plants and biological organisms; processing of biomedical materials for others being biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; processing of chemical materials for vaccine production being custom manufacture of vaccines

Development of new products for others; development of pharmaceutical preparations and medicines being research and development of new products for others; scientific research; medicine research services; research and development of new products; consulting services in the field of information technology development; biochemical research and analysis; biomedical research service; development of pharmaceutical preparations and medicines being research and development of new products for others; research and development of pharmaceuticals being research and development of new products for others
wuxi vaccines

General Information


Serial Number79331562
Word MarkWUXI VACCINES
Filing DateTuesday, July 20, 2021
Status700 - REGISTERED
Status DateTuesday, February 28, 2023
Registration Number6988097
Registration DateTuesday, February 28, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements


Goods and ServicesCustom assembling of materials for others being custom manufacture of pharmaceuticals, chemotherapy drugs, antibiotic medicines, and vaccines by pharmaceutical compounders; custom manufacture of pharmaceuticals medical preparation; customized production service being custom manufacturing of pharmaceuticals; customized production service being custom manufacturing of vaccines; medicinal materials processing being custom manufacture of pharmaceuticals; processing and treatment of chemical reagents, namely, custom production of reagents for scientific or medical research use; processing of pharmaceutical materials for others being processing of medicinal plants and biological organisms; processing of biomedical materials for others being biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; processing of chemical materials for vaccine production being custom manufacture of vaccines
Description of MarkThe mark consists of a stylized representation of a spiral and shaded circle next to four Chinese characters above the wording "WUXI VACCINES".
Transliteration StatementThe non-Latin characters in the mark transliterate to "YAO" "MING" "HAI" "DE" which mean "MEDICINE" "BRIGHT" "SEA" and "MORALITY" individually in English. The combination of the non-Latin characters has no meaning in a foreign language.
Disclaimer with Predetermined Text"WUXI VACCINES" AND THE NON-LATIN CHARACTER THAT TRANSLITERATES TO "YAO"
Goods and ServicesDevelopment of new products for others; development of pharmaceutical preparations and medicines being research and development of new products for others; scientific research; medicine research services; research and development of new products; consulting services in the field of information technology development; biochemical research and analysis; biomedical research service; development of pharmaceutical preparations and medicines being research and development of new products for others; research and development of pharmaceuticals being research and development of new products for others

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, January 21, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 21, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShanghai Vaccines Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCN

Party NameShanghai Vaccines Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCN

Party NameShanghai Vaccines Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCN

Trademark Events


Event DateEvent Description
Sunday, June 25, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 2, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 2, 2023FINAL DISPOSITION PROCESSED
Sunday, May 28, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 28, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, December 21, 2022NOTIFICATION PROCESSED BY IB
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 29, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 23, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 7, 2022EXAMINER'S AMENDMENT ENTERED
Monday, November 7, 2022ASSIGNED TO LIE
Monday, November 7, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 7, 2022EXAMINERS AMENDMENT E-MAILED
Monday, November 7, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 30, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 30, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 13, 2022REFUSAL PROCESSED BY IB
Tuesday, May 24, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 24, 2022REFUSAL PROCESSED BY MPU
Friday, April 15, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 14, 2022NON-FINAL ACTION WRITTEN
Wednesday, April 13, 2022ASSIGNED TO EXAMINER
Tuesday, January 25, 2022APPLICATION FILING RECEIPT MAILED
Friday, January 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 20, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB